{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:50:10Z","timestamp":1790193010697,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10620-021-07013-2","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T16:03:03Z","timestamp":1621526583000},"page":"854-862","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3188-7188","authenticated-orcid":false,"given":"Patricia P.","family":"Bloom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ventoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Tapper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"issue":"8","key":"7013_CR1","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.cgh.2016.04.009","volume":"14","author":"EB Tapper","year":"2016","unstructured":"Tapper EB, Halbert B, Mellinger J. Rates of and reasons for hospital readmissions in patients with cirrhosis: a multistate population-based cohort study. Clin Gastroenterol Hepatol. 2016;14:1181\u20138.e2.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"7013_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/hep.28414","volume":"64","author":"JS Bajaj","year":"2016","unstructured":"Bajaj JS, Reddy KR, Tandon P, Wong F, Kamath PS, Garcia-Tsao G et al. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology. 2016;64:200\u2013208.","journal-title":"Hepatology."},{"issue":"5","key":"7013_CR3","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/liv.14054","volume":"39","author":"AA Shaheen","year":"2019","unstructured":"Shaheen AA, Nguyen HH, Congly SE, Kaplan GG, Swain MG. Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States. Liver Int. 2019;39:878\u2013884.","journal-title":"Liver Int."},{"issue":"2","key":"7013_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/ajg.2011.314","volume":"107","author":"ML Volk","year":"2012","unstructured":"Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107:247\u2013252.","journal-title":"Am J Gastroenterol."},{"issue":"1","key":"7013_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.dld.2017.08.024","volume":"50","author":"BP Morales","year":"2018","unstructured":"Morales BP, Planas R, Bartoli R, Morillas RM, Sala M, Casas I et al. HEPACONTROL. A program that reduces early readmissions, mortality at 60 days, and healthcare costs in decompensated cirrhosis. Dig Liver Dis. 2018;50:76\u201383.","journal-title":"Dig Liver Dis."},{"issue":"7","key":"7013_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.cgh.2013.01.014","volume":"11","author":"AJ Wigg","year":"2013","unstructured":"Wigg AJ, McCormick R, Wundke R, Woodman RJ. Efficacy of a chronic disease management model for patients with chronic liver failure. Clin Gastroenterol Hepatol. 2013;11:850\u2013858.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"9","key":"7013_CR7","doi-asserted-by":"publisher","first-page":"e17770","DOI":"10.2196\/17770","volume":"8","author":"P Bloom","year":"2020","unstructured":"Bloom P, Wang T, Marx M, Tagerman M, Green B, Arvind A et al. A smartphone app to manage cirrhotic ascites among outpatients: feasibility study. JMIR Med Inform. 2020;8:e17770.","journal-title":"JMIR Med Inform."},{"issue":"13","key":"7013_CR8","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1016\/j.cgh.2019.09.001","volume":"17","author":"SM Siddique","year":"2019","unstructured":"Siddique SM, Porges S, Lane-Fall M, Mehta SJ, Schweickert W, Kinniry J et al. Reducing hospital admissions for paracentesis: a quality improvement intervention. Clin Gastroenterol Hepatol. 2019;17:2630\u20133.e2.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"2","key":"7013_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jhep.2013.03.010","volume":"59","author":"F Morando","year":"2013","unstructured":"Morando F, Maresio G, Piano S, Fasolato S, Cavallin M, Romano A et al. How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists. J Hepatol. 2013;59:257\u2013264.","journal-title":"J Hepatol."},{"issue":"4","key":"7013_CR10","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/hep.26359","volume":"57","author":"BA Runyon","year":"2013","unstructured":"Runyon BA. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651\u20131653.","journal-title":"Hepatology."},{"issue":"3","key":"7013_CR11","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1097\/MEG.0000000000000548","volume":"28","author":"M Pericleous","year":"2016","unstructured":"Pericleous M, Sarnowski A, Moore A, Fijten R, Zaman M. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. Eur J Gastroenterol Hepatol. 2016;28:e10\u2013e18.","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"12","key":"7013_CR12","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1007\/s10620-015-3744-3","volume":"60","author":"M Thomson","year":"2015","unstructured":"Thomson M, Volk M, Kim HM, Piette JD. An automated telephone monitoring system to identify patients with cirrhosis at risk of re-hospitalization. Dig Dis Sci. 2015;60:3563\u20133569. https:\/\/doi.org\/10.1007\/s10620-015-3744-3.","journal-title":"Dig Dis Sci."},{"issue":"37","key":"7013_CR13","doi-asserted-by":"publisher","first-page":"6868","DOI":"10.3748\/wjg.v23.i37.6868","volume":"23","author":"SM Seraj","year":"2017","unstructured":"Seraj SM, Campbell EJ, Argyropoulos SK, Wegermann K, Chung RT, Richter JM. Hospital readmissions in decompensated cirrhotics: factors pointing toward a prevention strategy. World J Gastroenterol. 2017;23:6868\u20136876.","journal-title":"World J Gastroenterol."},{"issue":"1","key":"7013_CR14","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/jhep.2003.50315","volume":"38","author":"KP Moore","year":"2003","unstructured":"Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology. 2003;38:258\u2013266.","journal-title":"Hepatology."},{"issue":"11","key":"7013_CR15","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","volume":"4","author":"R Planas","year":"2006","unstructured":"Planas R, Montoliu S, Ballest\u00e9 B, Rivera M, Miquel M, Masnou H et al. Natural history of patients hospitalized for management of cirrhotic ascites. Clin Gastroenterol Hepatol. 2006;4:1385\u20131394.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"7","key":"7013_CR16","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.cgh.2010.03.029","volume":"8","author":"S Montoliu","year":"2010","unstructured":"Montoliu S, Ballest\u00e9 B, Planas R, Alvarez MA, Rivera M, Miquel M et al. Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites. Clin Gastroenterol Hepatol. 2010;8:616\u2013622.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"7013_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/gut.2008.176495","volume":"59","author":"P Angeli","year":"2010","unstructured":"Angeli P, Fasolato S, Mazza E, Okolicsanyi L, Maresio G, Velo E et al. Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial. Gut. 2010;59:98\u2013104.","journal-title":"Gut."},{"issue":"5","key":"7013_CR18","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1365-2036.2005.02387.x","volume":"21","author":"I Pache","year":"2005","unstructured":"Pache I, Bilodeau M. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease. Aliment Pharmacol Ther. 2005;21:525\u2013529.","journal-title":"Aliment Pharmacol Ther."},{"issue":"4","key":"7013_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cld.2019.06.002","volume":"23","author":"D Adebayo","year":"2019","unstructured":"Adebayo D, Neong SF, Wong F. Ascites and hepatorenal syndrome. Clin Liver Dis. 2019;23:659\u2013682.","journal-title":"Clin Liver Dis."},{"issue":"1","key":"7013_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/ajg.2015.402","volume":"111","author":"S Le","year":"2016","unstructured":"Le S, Spelman T, Chong CP, Ha P, Sahhar L, Lim J et al. Could adherence to quality of care indicators for hospitalized patients with cirrhosis-related ascites improve clinical outcomes? Am J Gastroenterol. 2016;111:87\u201392.","journal-title":"Am J Gastroenterol."},{"issue":"7","key":"7013_CR21","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1053\/j.gastro.2015.08.045","volume":"149","author":"AF Peery","year":"2015","unstructured":"Peery AF, Crockett SD, Barritt AS, Dellon ES, Eluri S, Gangarosa LM et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015;149:1731\u201341.e3.","journal-title":"Gastroenterology."},{"issue":"9","key":"7013_CR22","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/MCG.0000000000000826","volume":"51","author":"SJ Scaglione","year":"2017","unstructured":"Scaglione SJ, Metcalfe L, Kliethermes S, Vasilyev I, Tsang R, Caines A et al. Early hospital readmissions and mortality in patients with decompensated cirrhosis enrolled in a large national health insurance administrative database. J Clin Gastroenterol. 2017;51:839\u2013844.","journal-title":"J Clin Gastroenterol."},{"issue":"10","key":"7013_CR23","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.dld.2019.03.016","volume":"51","author":"R Gaspar","year":"2019","unstructured":"Gaspar R, Rodrigues S, Silva M, Costa-Moreira P, Morais R, Andrade P et al. Predictive models of mortality and hospital readmission of patients with decompensated liver cirrhosis. Dig Liver Dis. 2019;51:1423\u20131429.","journal-title":"Dig Liver Dis."},{"issue":"4","key":"7013_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.14309\/ajg.0000000000000545","volume":"115","author":"B Kok","year":"2020","unstructured":"Kok B, Whitlock R, Ferguson T, Bailey RJ, Burak KW, Kowalczewski J et al. Health-related quality of life: a rapid predictor of hospitalization in patients with cirrhosis. Am J Gastroenterol. 2020;115:575\u2013583.","journal-title":"Am J Gastroenterol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07013-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-07013-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07013-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:14:13Z","timestamp":1744190053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-07013-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["7013"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-07013-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]},"assertion":[{"value":"17 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Bloom receives funding from the AASLD Advanced Transplant Hepatology Award and ACG Junior Faculty Award and has consulted for Synlogic Inc. Dr. Tapper receives funding from the National Institutes of Health (K23DK117055, KL2TR002241). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Tapper serves on advisory boards for Bausch Health, Rebiotix, and Mallinckrodt, consulted for Axcella, Kaleido, and Novo Nordisk. No other author has relevant conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}